Eisai Sues FDA To Reclaim Lost Exclusivity For 2 Drugs
Eisai Inc. on Friday sued the U.S. Food and Drug Administration in D.C. federal court for refusing to adjust the approval dates of two prescription drugs to reflect the actual dates...To view the full article, register now.
Already a subscriber? Click here to view full article